author-photo

Diana Marquis

University of Rochester

15

Papers

467

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.

2009 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (63)
A phase 2 study of concurrent fludarabine and rituximab for the treatment of marginal zone lymphomas

2009 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (70)
Bortezomib and Gemcitabine in Relapsed Hodgkin Lymphoma (HL).

2007 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Combination Immunotherapy with a CpG Oligonucleotide and Rituximab (R) Augments the Immunological Response and Favorably Alters the Malignant Microenvironment of Follicular Lymphoma (FL).

2006 Blood
Show All
- Source
- Cite
- Save
Citations (2)
CpG Oligonucleotide (1018 ISS) May Overcome Rituximab (R) Resistance in Follicular Lymphoma (FL) through Enhanced ADCC, T Cell Expansion, and Alteration of Tumor Microenvironment.

2005 Blood
Show All
- Source
- Cite
- Save
Citations (2)
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.

2003 Cancer Gene Therapy
Show All
- Source
- Cite
- Save
Citations (52)
Active specific immunotherapy for metastatic colorectal carcinoma : Phase I study of an allogeneic cell vaccine plus low-dose interleukin-1α

1999 Journal of Immunotherapy
Show All
- Source
- Cite
- Save
Citations (29)
Interleukin 1 as an Adjuvant for Active Specific Immunotherapy in a Murine Tumor Model

1990 Cancer Research
- Craig S. McCune
- Diana Marquis
Show All
- Source
- Cite
- Save
Citations (56)
Renal cell carcinoma treated by vaccines for active specific immunotherapy : correlation of survival with skin testing by autologous tumor cells

1990 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (90)
Human hybrid tumor cells: observations on their production and clinical effects.

1987 Journal of biological response modifiers
Show All
- Source
- Cite
- Save
Citations (1)